Skip to main content
Top
Published in: BMC Neurology 1/2024

Open Access 01-12-2024 | Autoimmune Encephalitis | Case Report

A case of NMDAR Encephalitis with muscular pain as the main presentation

Authors: Baizhu Li, Xiuli Shang

Published in: BMC Neurology | Issue 1/2024

Login to get access

Abstract

Background

Persistent somatoform pain disorder (PSPD) is often the initial diagnosis in patients seeking treatment in psychiatric departments, making it challenging to consider organic nervous system diseases. However, autoimmune encephalitis can present with atypical initial symptoms, leading to misdiagnosis or missed diagnosis. Lumbar puncture, with antibody support, plays a crucial role in diagnosing autoimmune encephalitis.

Case presentation

This report describes a 40-year-old male adult patient who was initially diagnosed with persistent somatoform pain disorder in 2022. The patient reported a reduction in pain while resting on his back. There were no fever or relevant medical history. Despite 8 months of symptomatic treatment, the symptoms did not improve. Moreover, the patient developed confusion, gibberish speech, non-cooperation during questioning, and increased frequency and amplitude of upper limb convulsions. Lumbar puncture revealed elevated protein levels and protein-cell dissociation. The autoimmune encephalitis antibody NMDAR (+) was detected, leading to a diagnosis of autoimmune encephalitis (NMDAR).

Conclusion

Autoimmune encephalitis (NMDAR), starting with persistent somatoform pain (PSPD), often presents with atypical symptoms and can be easily misdiagnosed. Therefore, it is important to consider the possibility of organic nervous system disease in time, and to test serum or cerebrospinal fluid antibodies to rule out organic nervous system disease after symptomatic treatment of mental disorders is ineffective. This approach facilitates the early diagnosis of autoimmune encephalitis and other underlying organic neurological disorders.
Literature
1.
2.
go back to reference Restrepo-Martínez M, et al. Neuropsychiatric aspects of anti-NMDA receptor encephalitis. Revista Alergia Mexico (Tecamachalco Puebla Mexico: 1993). 2021;68:251–63.CrossRefPubMed Restrepo-Martínez M, et al. Neuropsychiatric aspects of anti-NMDA receptor encephalitis. Revista Alergia Mexico (Tecamachalco Puebla Mexico: 1993). 2021;68:251–63.CrossRefPubMed
3.
go back to reference Peery HE, et al. Anti-NMDA receptor encephalitis. The disorder, the diagnosis and the immunobiology. Autoimmun rev. 2012;11:863–72.CrossRefPubMed Peery HE, et al. Anti-NMDA receptor encephalitis. The disorder, the diagnosis and the immunobiology. Autoimmun rev. 2012;11:863–72.CrossRefPubMed
4.
go back to reference Karcioglu O, Topacoglu H, Dikme O, Dikme O. A systematic review of the pain scales in adults: which to use? Am J Emerg Med. 2018;36:707–14.CrossRefPubMed Karcioglu O, Topacoglu H, Dikme O, Dikme O. A systematic review of the pain scales in adults: which to use? Am J Emerg Med. 2018;36:707–14.CrossRefPubMed
5.
go back to reference Ciesielska N, et al. Is the Montreal Cognitive Assessment (MoCA) test better suited than the Mini-mental State Examination (MMSE) in mild cognitive impairment (MCI) detection among people aged over 60? Meta-analysis. Psychiatr Pol. 2016;50:1039–52.CrossRefPubMed Ciesielska N, et al. Is the Montreal Cognitive Assessment (MoCA) test better suited than the Mini-mental State Examination (MMSE) in mild cognitive impairment (MCI) detection among people aged over 60? Meta-analysis. Psychiatr Pol. 2016;50:1039–52.CrossRefPubMed
6.
7.
go back to reference Kanniah G, Kumar R, Subramaniam G. Receptor encephalitis: a challenge in Psychiatric Settings. J Psychiatr Pract. 2022;28:78–83.CrossRefPubMed Kanniah G, Kumar R, Subramaniam G. Receptor encephalitis: a challenge in Psychiatric Settings. J Psychiatr Pract. 2022;28:78–83.CrossRefPubMed
8.
go back to reference Koparal B, Çiçek S, Taner ME, Kuruoğlu A. A Rapidly Progressive Case of Anti-NMDAR Encephalitis with Primary Psychiatric symptoms. Psychiatria Danubina. 2021;33:177–9.CrossRefPubMed Koparal B, Çiçek S, Taner ME, Kuruoğlu A. A Rapidly Progressive Case of Anti-NMDAR Encephalitis with Primary Psychiatric symptoms. Psychiatria Danubina. 2021;33:177–9.CrossRefPubMed
9.
go back to reference Norton D, Pesce MS, Gill D, Pounding Problem A. A case of recurrent headache caused by Anti-NMDA receptor encephalitis. J Emerg Med. 2021;60:345–8.CrossRefPubMed Norton D, Pesce MS, Gill D, Pounding Problem A. A case of recurrent headache caused by Anti-NMDA receptor encephalitis. J Emerg Med. 2021;60:345–8.CrossRefPubMed
11.
go back to reference Dalmau J, et al. An update on anti-NMDA receptor encephalitis for neurologists and psychiatrists: mechanisms and models. Lancet Neurol. 2019;18:1045–57.CrossRefPubMed Dalmau J, et al. An update on anti-NMDA receptor encephalitis for neurologists and psychiatrists: mechanisms and models. Lancet Neurol. 2019;18:1045–57.CrossRefPubMed
12.
go back to reference Seery N, Butzkueven H, O’Brien TJ, Monif M. Rare antibody-mediated and seronegative autoimmune encephalitis: an update. Autoimmun rev. 2022;21:103118.CrossRefPubMed Seery N, Butzkueven H, O’Brien TJ, Monif M. Rare antibody-mediated and seronegative autoimmune encephalitis: an update. Autoimmun rev. 2022;21:103118.CrossRefPubMed
Metadata
Title
A case of NMDAR Encephalitis with muscular pain as the main presentation
Authors
Baizhu Li
Xiuli Shang
Publication date
01-12-2024
Publisher
BioMed Central
Published in
BMC Neurology / Issue 1/2024
Electronic ISSN: 1471-2377
DOI
https://doi.org/10.1186/s12883-024-03652-w

Other articles of this Issue 1/2024

BMC Neurology 1/2024 Go to the issue